CAN chart, page-50

They are the leading two players on the ASX easily, but there's numerous reasons as to why CAN is and should be ahead of AC8 in market cap:
- CAN is in production, AC8 is not
- Further to the above point, first mover advantage has been very significant for the company (first licences, first permits)
- CAN is tied in with AgVic/Vic State Govt, the most advanced state in terms of medicinal cannabis
- CAN has stated there is offtake for any product grown... therefore revenues imminent
- Increasing to 800 square metres of growing capacity before end of year, with Phase 3 facility (a further ~5,000 square metres) being planned
- 20% owned by Aurora, who we've seen make a takeover offer for a Canadian rival in the last week. A takeover of CAN may be possible.
- Outstanding board/management, Allan McCallum also on boards of MVP (also flying) & TGR, Doug Rathbone & Geoff Pearce both extremely successful, well-connected NEDs
- Much cleaner capital structure

Now come back and tell me AC8 is in a better position. If having two females on the board is your argument then good luck to you.

The positive is in my view the space is going to be big enough for multiple players anyway.